
IHC-P analysis of human lung carcinoma tissue using GTX86925 Caspase 7 (cleaved Asp198) antibody. The picture on the right is blocked with the synthesized peptide.
Caspase 7 (cleaved Asp198) antibody
GTX86925
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetCASP7
Overview
- SupplierGeneTex
- Product NameCaspase 7 (cleaved Asp198) antibody
- Delivery Days Customer9
- Antibody SpecificityCaspase 7 (cleaved Asp198) antibody detects endogenous levels of fragment of activated Caspase 7 resulting from cleavage adjacent to Asp198.
- Application Supplier NoteWB: 1:500~1:1000. IHC-P: 1:50~1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID840
- Target nameCASP7
- Target descriptioncaspase 7
- Target synonymsapoptotic protease MCH-3; CASP-7; caspase 7, apoptosis-related cysteine peptidase; caspase 7, apoptosis-related cysteine protease; caspase-7; CMH-1; ICE-LAP3; ICE-like apoptotic protease 3; LICE2; MCH3
- HostRabbit
- IsotypeIgG
- Protein IDP55210
- Protein NameCaspase-7
- Scientific DescriptionThis gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. The precursor of the encoded protein is cleaved by caspase 3 and 10, is activated upon cell death stimuli and induces apoptosis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Orabase-Formulated Benzalkonium Chloride Effectively Suppressed Oral Potentially Malignant Disorder In Vitro and In Vivo. Wang YY et al., 2020 Mar 31, ACS OmegaRead more